Spots Global Cancer Trial Database for mpm
Every month we try and update this database with for mpm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Real World Study of MPM in China | NCT05042557 | Malignant Pleur... Diagnoses Disea... Treatments Prognosis | 18 Years - | ChineseAMS | ||
| A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma | NCT04897022 | Malignant Pleur... | Pembrolizumab IMPRINT | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma | NCT02863055 | Malignant Pleur... | Nintedanib Placebo | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy | NCT01769547 | Advanced Malign... MPM | Dovitinib | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed | NCT01098266 | Malignant Pleur... | NGR-hTNF plus B... Placebo plus Be... | 18 Years - | AGC Biologics S.p.A. | |
| A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma | NCT04897022 | Malignant Pleur... | Pembrolizumab IMPRINT | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) | NCT02194231 | Malignant Pleur... | Trabectedin | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma | NCT02611037 | Malignant Pleur... Mesothelioma | Cisplatin Methotrexate Gemcitabine Lung Cancer Sym... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. | NCT01721018 | Malignant Pleur... | HSV1716 Intra-p... | 18 Years - | Virttu Biologics Limited | |
| A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma | NCT04897022 | Malignant Pleur... | Pembrolizumab IMPRINT | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma | NCT02991482 | Pleural Mesothe... | Pembrolizumab Gemcitabine Vinorelbine | 18 Years - | ETOP IBCSG Partners Foundation | |
| Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma | NCT02863055 | Malignant Pleur... | Nintedanib Placebo | 18 Years - 90 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma | NCT01675765 | Malignant Pleur... | Immunotherapy p... Immunotherapy w... | 18 Years - | Aduro Biotech, Inc. | |
| Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma | NCT02293005 | Lung Cancer Mesothelioma | Alisertib | 18 Years - | M.D. Anderson Cancer Center | |
| Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. | NCT01721018 | Malignant Pleur... | HSV1716 Intra-p... | 18 Years - | Virttu Biologics Limited | |
| Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM | NCT01358084 | Advanced Malign... | NGR-hTNF Placebo Best Supportive... | 18 Years - | AGC Biologics S.p.A. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
